Aurobindo Pharma Opens Four Plants in Andhra Pradesh

Today, Aurobindo Pharma announced the completion of four modern 6-AAA injectables and granulation manufacturing facilities in the corporate bracket through its fully owned subsidiaries.

Penicillin -G (Pen-G) facility, in an SEZ at Kakinada, Andhra Pradesh, has a manufacturing capacity of 15,000 tonnes annually and 1.8 lakh tonnes annual generation of glucose. In comparison, the 6-Amino Penicillanic Acid plant produces 3,600 tonnes competently. 

The Rs 2,400 crore plant at Pen-G is counted on the plant trial operations to begin in May, and full commercial production will happen in a few months. The production scale-up will occur within Q2 of the current fiscal year, as per a previous senior official of the company.

Therefore, the factory was sanctioned under the Production Linked Incentive (PLI) Scheme for the creation of domestic manufacturing capacity for critical key starting materials (KSMs), drug intermediates, and active pharmaceutical ingredients (APIs) in the country.

The injectable plant can produce 285 million vials/ampoules annually, and the coarse products plant produces 13,200 tonnes/Anne. Aurobindo said these facilities are expected to constitute the major production base of the product.